These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21928727)

  • 1. Development and in vitro characterization of floating microspheres bearing tramadol HC1.
    Chaurasia D; Kaushik K; Bhardwaj P; Chaurasia H; Jain SK; Shobhna S
    Acta Pol Pharm; 2011; 68(5):795-801. PubMed ID: 21928727
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.
    He S; Zhu J; Xie F
    Pharmazie; 2010 Jul; 65(7):467-70. PubMed ID: 20662312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of oral suspensions of microparticles of ethylcellulose with tramadol.
    Morales ME; Ruiz MA; López G; Gallardo V
    Drug Dev Ind Pharm; 2010 Aug; 36(8):885-92. PubMed ID: 20184418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-phase hydrogel for buccal delivery of tramadol.
    Kamel R; Mahmoud A; El-Feky G
    Drug Dev Ind Pharm; 2012 Apr; 38(4):468-83. PubMed ID: 21942308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tramadol loading, release and iontophoretic characteristics of ion-exchange fiber.
    Gao Y; Yuan J; Liu H; Yang Y; Hou Y; Li S
    Int J Pharm; 2014 Apr; 465(1-2):102-11. PubMed ID: 24530391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, in vitro characterization, pharmacokinetic, and pharmacodynamic evaluation of chitosan-based plumbagin microspheres in mice bearing B16F1 melanoma.
    Mandala Rayabandla SK; Aithal K; Anandam A; Shavi G; Nayanabhirama U; Arumugam K; Musmade P; Bhat K; Bola Sadashiva SR
    Drug Deliv; 2010 Apr; 17(3):103-13. PubMed ID: 20100068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro - in vivo evaluation of a new oral dosage form of tramadol hydrochloride--controlled-release capsules filled with coated pellets.
    Szkutnik-Fiedler D; Balcerkiewicz M; Sawicki W; Grabowski T; Grześkowiak E; Mazgalski J; Urjasz H
    Acta Pol Pharm; 2014; 71(3):469-75. PubMed ID: 25265827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
    Belgamwar VS; Patel HS; Joshi AS; Agrawal A; Surana SJ; Tekade AR
    Drug Deliv; 2011 Jul; 18(5):353-60. PubMed ID: 21351825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-genipin microspheres for the controlled release of drugs: clarithromycin, tramadol and heparin.
    Harris R; Lecumberri E; Heras A
    Mar Drugs; 2010 May; 8(6):1750-62. PubMed ID: 20631867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.
    Hu LD; Xing QB; Shang C; Liu W; Liu C; Luo ZL; Xu HX
    Pharmazie; 2010 Jul; 65(7):477-80. PubMed ID: 20662314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation.
    Ammar HO; Ghorab M; El-Nahhas SA; Kamel R
    AAPS PharmSciTech; 2009; 10(1):7-20. PubMed ID: 19132537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
    Negro S; Salama A; Sánchez Y; Azuara ML; Barcia E
    J Clin Pharm Ther; 2007 Oct; 32(5):441-4. PubMed ID: 17875108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
    Ahad HA; Ishaq BM; Shaik M; Bandagisa F
    Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
    Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
    Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in-vitro characterization of tramadol-loaded carrier erythrocytes for long-term intravenous delivery.
    Foroozesh M; Hamidi M; Zarrin A; Mohammadi-Samani S; Montaseri H
    J Pharm Pharmacol; 2011 Mar; 63(3):322-32. PubMed ID: 21749379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PREDICTIVE PHARMACOKINETICS OF TRAMADOL HYDROCHLORIDE FLOATING TABLETS.
    Wang J; Zhang Y; Guo Z; Tao Q; Wang Y; Zhou W; Ma X; Li Z
    Acta Pol Pharm; 2016; 73(3):755-9. PubMed ID: 27476294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of drug release from capsules using high frequency energy transmission systems.
    Gröning R; Bensmann H; Müller RS
    Int J Pharm; 2008 Nov; 364(1):9-13. PubMed ID: 18682281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties.
    Foda NH; El-laithy HM; Tadros MI
    Drug Dev Ind Pharm; 2004 Apr; 30(4):369-79. PubMed ID: 15132179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.